 | • レポートコード：QY20ST-06909 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のイホスファミド市場について種類別（0.5g/バイアル、1g/バイアル）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・イホスファミド市場の概要 ・世界の主要地域別イホスファミド市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のイホスファミド市場規模2015-2026：種類別（0.5g/バイアル、1g/バイアル） ・世界のイホスファミド市場規模2015-2026：用途別（病院薬局、小売薬局、オンライン薬局） ・イホスファミドの北米市場規模2015-2020 ・イホスファミドのヨーロッパ市場規模2015-2020 ・イホスファミドの中国市場規模2015-2020 ・イホスファミドの日本市場規模2015-2020 ・イホスファミドの東南アジア市場規模2015-2020 ・イホスファミドのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・イホスファミドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・イホスファミドの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Ifosfamide (CAS 3778-73-2) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Ifosfamide (CAS 3778-73-2) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Ifosfamide (CAS 3778-73-2), C7H15Cl2N2O2P, the formula weight is 261.09.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ifosfamide (CAS 3778-73-2) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Ifosfamide (CAS 3778-73-2) industry.
Based on our recent survey, we have several different scenarios about the Ifosfamide (CAS 3778-73-2) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Ifosfamide (CAS 3778-73-2) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Ifosfamide (CAS 3778-73-2) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Ifosfamide (CAS 3778-73-2) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Ifosfamide (CAS 3778-73-2) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Ifosfamide (CAS 3778-73-2) market. The report also includes nautical information, where it shows Ifosfamide (CAS 3778-73-2) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Ifosfamide (CAS 3778-73-2) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Ifosfamide (CAS 3778-73-2) market.
Ifosfamide is mainly used for soft tissue tumors, testicular tumors, malignant lymphoma, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors.
Geographical Analysis:
Based on region, the global Ifosfamide (CAS 3778-73-2) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Ifosfamide (CAS 3778-73-2) market are
Lingnan Pharma
Qilu Pharma
Ruiying Pharma
Quanxing Pharma
Baxter
Hengrui Medicine
Jinrui Pharma
Taisheng Zhiyao
TEVA
Mylan
Pfizer
GLS Pharma
Segment by Type
0.5g/Vial
1g/Vial
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Ifosfamide (CAS 3778-73-2) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Ifosfamide (CAS 3778-73-2) market.
• The market share of the global Ifosfamide (CAS 3778-73-2) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Ifosfamide (CAS 3778-73-2) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Ifosfamide (CAS 3778-73-2) market.
1 Ifosfamide (CAS 3778-73-2) Market Overview
1.1 Ifosfamide (CAS 3778-73-2) Product Scope
1.2 Ifosfamide (CAS 3778-73-2) Segment by Type
1.2.1 Global Ifosfamide (CAS 3778-73-2) Sales by Type (2020-2026)
1.2.2 0.5g/Vial
1.2.3 1g/Vial
1.3 Ifosfamide (CAS 3778-73-2) Segment by Application
1.3.1 Global Ifosfamide (CAS 3778-73-2) Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Ifosfamide (CAS 3778-73-2) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Ifosfamide (CAS 3778-73-2) Sales Growth Rate (2015-2026)
1.4.2 Global Ifosfamide (CAS 3778-73-2) Revenue and Growth Rate (2015-2026)
1.4.3 Global Ifosfamide (CAS 3778-73-2) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Ifosfamide (CAS 3778-73-2) Industry Impact
1.5.1 How the Covid-19 is Affecting the Ifosfamide (CAS 3778-73-2) Industry
1.5.1.1 Ifosfamide (CAS 3778-73-2) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Ifosfamide (CAS 3778-73-2) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Ifosfamide (CAS 3778-73-2) Players to Combat Covid-19 Impact
2 Ifosfamide (CAS 3778-73-2) Estimate and Forecast by Region
2.1 Global Ifosfamide (CAS 3778-73-2) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Ifosfamide (CAS 3778-73-2) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Ifosfamide (CAS 3778-73-2) Sales Market Share by Region (2015-2020)
2.2.2 Global Ifosfamide (CAS 3778-73-2) Revenue Market Share by Region (2015-2020)
2.3 Global Ifosfamide (CAS 3778-73-2) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Ifosfamide (CAS 3778-73-2) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Ifosfamide (CAS 3778-73-2) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Ifosfamide (CAS 3778-73-2) Estimates and Projections (2015-2026)
2.4.2 Europe Ifosfamide (CAS 3778-73-2) Estimates and Projections (2015-2026)
2.4.3 China Ifosfamide (CAS 3778-73-2) Estimates and Projections (2015-2026)
2.4.4 Japan Ifosfamide (CAS 3778-73-2) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Ifosfamide (CAS 3778-73-2) Estimates and Projections (2015-2026)
2.4.6 India Ifosfamide (CAS 3778-73-2) Estimates and Projections (2015-2026)
3 Global Ifosfamide (CAS 3778-73-2) Competition Landscape by Players
3.1 Global Top Ifosfamide (CAS 3778-73-2) Players by Sales (2015-2020)
3.2 Global Top Ifosfamide (CAS 3778-73-2) Players by Revenue (2015-2020)
3.3 Global Ifosfamide (CAS 3778-73-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ifosfamide (CAS 3778-73-2) as of 2019)
3.4 Global Ifosfamide (CAS 3778-73-2) Average Price by Company (2015-2020)
3.5 Manufacturers Ifosfamide (CAS 3778-73-2) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Ifosfamide (CAS 3778-73-2) Players (Opinion Leaders)
4 Global Ifosfamide (CAS 3778-73-2) Market Size by Type
4.1 Global Ifosfamide (CAS 3778-73-2) Historic Market Review by Type (2015-2020)
4.1.1 Global Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
4.1.2 Global Ifosfamide (CAS 3778-73-2) Revenue Market Share by Type (2015-2020)
4.1.3 Global Ifosfamide (CAS 3778-73-2) Price by Type (2014-2020)
4.2 Global Ifosfamide (CAS 3778-73-2) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Ifosfamide (CAS 3778-73-2) Sales Forecast by Type (2021-2026)
4.2.2 Global Ifosfamide (CAS 3778-73-2) Revenue Forecast by Type (2021-2026)
4.2.3 Global Ifosfamide (CAS 3778-73-2) Price Forecast by Type (2021-2026)
5 Global Ifosfamide (CAS 3778-73-2) Market Size by Application
5.1 Global Ifosfamide (CAS 3778-73-2) Historic Market Review by Application (2015-2020)
5.1.1 Global Ifosfamide (CAS 3778-73-2) Sales Market Share by Application (2015-2020)
5.1.2 Global Ifosfamide (CAS 3778-73-2) Revenue Market Share by Application (2015-2020)
5.1.3 Global Ifosfamide (CAS 3778-73-2) Price by Application (2015-2020)
5.2 Global Ifosfamide (CAS 3778-73-2) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Ifosfamide (CAS 3778-73-2) Sales Forecast by Application (2021-2026)
5.2.2 Global Ifosfamide (CAS 3778-73-2) Revenue Forecast by Application (2021-2026)
5.2.3 Global Ifosfamide (CAS 3778-73-2) Price Forecast by Application (2021-2026)
3 North America Ifosfamide (CAS 3778-73-2) Market Facts & Figures
3.2 North America Ifosfamide (CAS 3778-73-2) Sales Market Share by Company (2015-2020)
3.3 North America Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
3.4 North America Ifosfamide (CAS 3778-73-2) Sales Market Share by Application (2015-2020)
4 Europe Ifosfamide (CAS 3778-73-2) Market Facts & Figures
4.2 Europe Ifosfamide (CAS 3778-73-2) Sales Market Share by Company (2015-2020)
4.3 Europe Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
4.4 Europe Ifosfamide (CAS 3778-73-2) Sales Market Share by Application (2015-2020)
5 China Ifosfamide (CAS 3778-73-2) Market Facts & Figures
5.2 China Ifosfamide (CAS 3778-73-2) Sales Market Share by Company (2015-2020)
5.3 China Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
5.4 China Ifosfamide (CAS 3778-73-2) Sales Market Share by Application (2015-2020)
6 Japan Ifosfamide (CAS 3778-73-2) Market Facts & Figures
6.2 Japan Ifosfamide (CAS 3778-73-2) Sales Market Share by Company (2015-2020)
6.3 Japan Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
6.4 Japan Ifosfamide (CAS 3778-73-2) Sales Market Share by Application (2015-2020)
7 Southeast Asia Ifosfamide (CAS 3778-73-2) Market Facts & Figures
7.2 Southeast Asia Ifosfamide (CAS 3778-73-2) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Ifosfamide (CAS 3778-73-2) Sales Market Share by Application (2015-2020)
8 India Ifosfamide (CAS 3778-73-2) Market Facts & Figures
8.2 India Ifosfamide (CAS 3778-73-2) Sales Market Share by Company (2015-2020)
8.3 India Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
8.4 India Ifosfamide (CAS 3778-73-2) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Ifosfamide (CAS 3778-73-2) Business
12.1 Lingnan Pharma
12.1.1 Lingnan Pharma Ifosfamide (CAS 3778-73-2) Corporation Information
12.1.2 Lingnan Pharma Ifosfamide (CAS 3778-73-2) Business Overview and Total Revenue
12.1.3 Lingnan Pharma Ifosfamide (CAS 3778-73-2) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Lingnan Pharma Ifosfamide (CAS 3778-73-2) Products Offered
12.1.5 Lingnan Pharma Recent Development
12.2 Qilu Pharma
12.2.1 Qilu Pharma Ifosfamide (CAS 3778-73-2) Corporation Information
12.2.2 Qilu Pharma Ifosfamide (CAS 3778-73-2) Business Overview and Total Revenue
12.2.3 Qilu Pharma Ifosfamide (CAS 3778-73-2) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Qilu Pharma Ifosfamide (CAS 3778-73-2) Products Offered
12.2.5 Qilu Pharma Recent Development
12.3 Ruiying Pharma
12.3.1 Ruiying Pharma Ifosfamide (CAS 3778-73-2) Corporation Information
12.3.2 Ruiying Pharma Ifosfamide (CAS 3778-73-2) Business Overview and Total Revenue
12.3.3 Ruiying Pharma Ifosfamide (CAS 3778-73-2) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Ruiying Pharma Ifosfamide (CAS 3778-73-2) Products Offered
12.3.5 Ruiying Pharma Recent Development
12.4 Quanxing Pharma
12.4.1 Quanxing Pharma Ifosfamide (CAS 3778-73-2) Corporation Information
12.4.2 Quanxing Pharma Ifosfamide (CAS 3778-73-2) Business Overview and Total Revenue
12.4.3 Quanxing Pharma Ifosfamide (CAS 3778-73-2) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Quanxing Pharma Ifosfamide (CAS 3778-73-2) Products Offered
12.4.5 Quanxing Pharma Recent Development
12.5 Baxter
12.5.1 Baxter Ifosfamide (CAS 3778-73-2) Corporation Information
12.5.2 Baxter Ifosfamide (CAS 3778-73-2) Business Overview and Total Revenue
12.5.3 Baxter Ifosfamide (CAS 3778-73-2) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Baxter Ifosfamide (CAS 3778-73-2) Products Offered
12.5.5 Baxter Recent Development
12.6 Hengrui Medicine
12.6.1 Hengrui Medicine Ifosfamide (CAS 3778-73-2) Corporation Information
12.6.2 Hengrui Medicine Ifosfamide (CAS 3778-73-2) Business Overview and Total Revenue
12.6.3 Hengrui Medicine Ifosfamide (CAS 3778-73-2) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Hengrui Medicine Ifosfamide (CAS 3778-73-2) Products Offered
12.6.5 Hengrui Medicine Recent Development
12.7 Jinrui Pharma
12.7.1 Jinrui Pharma Ifosfamide (CAS 3778-73-2) Corporation Information
12.7.2 Jinrui Pharma Ifosfamide (CAS 3778-73-2) Business Overview and Total Revenue
12.7.3 Jinrui Pharma Ifosfamide (CAS 3778-73-2) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Jinrui Pharma Ifosfamide (CAS 3778-73-2) Products Offered
12.7.5 Jinrui Pharma Recent Development
12.8 Taisheng Zhiyao
12.8.1 Taisheng Zhiyao Ifosfamide (CAS 3778-73-2) Corporation Information
12.8.2 Taisheng Zhiyao Ifosfamide (CAS 3778-73-2) Business Overview and Total Revenue
12.8.3 Taisheng Zhiyao Ifosfamide (CAS 3778-73-2) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Taisheng Zhiyao Ifosfamide (CAS 3778-73-2) Products Offered
12.8.5 Taisheng Zhiyao Recent Development
12.9 TEVA
12.9.1 TEVA Ifosfamide (CAS 3778-73-2) Corporation Information
12.9.2 TEVA Ifosfamide (CAS 3778-73-2) Business Overview and Total Revenue
12.9.3 TEVA Ifosfamide (CAS 3778-73-2) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 TEVA Ifosfamide (CAS 3778-73-2) Products Offered
12.9.5 TEVA Recent Development
12.10 Mylan
12.10.1 Mylan Ifosfamide (CAS 3778-73-2) Corporation Information
12.10.2 Mylan Ifosfamide (CAS 3778-73-2) Business Overview and Total Revenue
12.10.3 Mylan Ifosfamide (CAS 3778-73-2) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Mylan Ifosfamide (CAS 3778-73-2) Products Offered
12.10.5 Mylan Recent Development
12.11 Pfizer
12.11.1 Pfizer Ifosfamide (CAS 3778-73-2) Corporation Information
12.11.2 Pfizer Ifosfamide (CAS 3778-73-2) Business Overview and Total Revenue
12.11.3 Pfizer Ifosfamide (CAS 3778-73-2) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Ifosfamide (CAS 3778-73-2) Products Offered
12.11.5 Pfizer Recent Development
12.12 GLS Pharma
12.12.1 GLS Pharma Ifosfamide (CAS 3778-73-2) Corporation Information
12.12.2 GLS Pharma Ifosfamide (CAS 3778-73-2) Business Overview and Total Revenue
12.12.3 GLS Pharma Ifosfamide (CAS 3778-73-2) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 GLS Pharma Ifosfamide (CAS 3778-73-2) Products Offered
12.12.5 GLS Pharma Recent Development
13 Ifosfamide (CAS 3778-73-2) Manufacturing Cost Analysis
13.1 Ifosfamide (CAS 3778-73-2) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Ifosfamide (CAS 3778-73-2)
13.4 Ifosfamide (CAS 3778-73-2) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Ifosfamide (CAS 3778-73-2) Distributors List
14.3 Ifosfamide (CAS 3778-73-2) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Ifosfamide (CAS 3778-73-2) Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Ifosfamide (CAS 3778-73-2) Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Ifosfamide (CAS 3778-73-2) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Ifosfamide (CAS 3778-73-2) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Ifosfamide (CAS 3778-73-2) Players to Combat Covid-19 Impact
Table 8. Global Market Ifosfamide (CAS 3778-73-2) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Ifosfamide (CAS 3778-73-2) Sales (Kg) by Region (2015-2020)
Table 10. Global Ifosfamide (CAS 3778-73-2) Sales Market Share by Region (2015-2020)
Table 11. Global Ifosfamide (CAS 3778-73-2) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Ifosfamide (CAS 3778-73-2) Revenue Share by Region (2015-2020)
Table 13. Global Ifosfamide (CAS 3778-73-2) Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Ifosfamide (CAS 3778-73-2) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Ifosfamide (CAS 3778-73-2) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Ifosfamide (CAS 3778-73-2) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Ifosfamide (CAS 3778-73-2) (Kg) of Key Companies (2015-2020)
Table 18. Global Ifosfamide (CAS 3778-73-2) Sales Share by Company (2015-2020)
Table 19. Global Ifosfamide (CAS 3778-73-2) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Ifosfamide (CAS 3778-73-2) Revenue Share by Company (2015-2020)
Table 21. Global Ifosfamide (CAS 3778-73-2) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ifosfamide (CAS 3778-73-2) as of 2019)
Table 22. Global Ifosfamide (CAS 3778-73-2) Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Ifosfamide (CAS 3778-73-2) Manufacturing Sites and Area Served
Table 24. Manufacturers Ifosfamide (CAS 3778-73-2) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Ifosfamide (CAS 3778-73-2) Players
Table 27. Global Ifosfamide (CAS 3778-73-2) Sales (Kg) by Type (2015-2020)
Table 28. Global Ifosfamide (CAS 3778-73-2) Sales Share by Type (2015-2020)
Table 29. Global Ifosfamide (CAS 3778-73-2) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Ifosfamide (CAS 3778-73-2) Price (Kg) by Type (2015-2020)
Table 31. Global Ifosfamide (CAS 3778-73-2) Sales Share by Type (2021-2026)
Table 32. Global Ifosfamide (CAS 3778-73-2) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Ifosfamide (CAS 3778-73-2) Revenue Share by Type (2021-2026)
Table 34. Global Ifosfamide (CAS 3778-73-2) Price (Kg) by Type (2021-2026)
Table 35. Global Ifosfamide (CAS 3778-73-2) Sales (Kg) by Application (2015-2020)
Table 36. Global Ifosfamide (CAS 3778-73-2) Sales Share by Application (2015-2020)
Table 37. Global Ifosfamide (CAS 3778-73-2) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Ifosfamide (CAS 3778-73-2) Price (Kg) by Application (2015-2020)
Table 39. Global Ifosfamide (CAS 3778-73-2) Sales (Kg) by Application (2021-2026)
Table 40. Global Ifosfamide (CAS 3778-73-2) Sales Share by Application (2021-2026)
Table 41. Global Ifosfamide (CAS 3778-73-2) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Ifosfamide (CAS 3778-73-2) Revenue Share by Application (2021-2026)
Table 43. Global Ifosfamide (CAS 3778-73-2) Price (Kg) by Application (2021-2026)
Table 44. United States Ifosfamide (CAS 3778-73-2) Sales (Kg) by Company (2015-2020)
Table 45. United States Ifosfamide (CAS 3778-73-2) Sales Market Share by Company (2015-2020)
Table 46. United States Ifosfamide (CAS 3778-73-2) Sales (Kg) by Type (2015-2020)
Table 47. United States Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
Table 48. United States Ifosfamide (CAS 3778-73-2) Sales (Kg) by Application (2015-2020)
Table 49. United States Ifosfamide (CAS 3778-73-2) Sales Market Share by Application (2015-2020)
Table 50. Europe Ifosfamide (CAS 3778-73-2) Sales (Kg) by Company (2015-2020)
Table 51. Europe Ifosfamide (CAS 3778-73-2) Sales Market Share by Company (2015-2020)
Table 52. Europe Ifosfamide (CAS 3778-73-2) Sales (Kg) by Type (2015-2020)
Table 53. Europe Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
Table 54. Europe Ifosfamide (CAS 3778-73-2) Sales (Kg) by Application (2015-2020)
Table 55. Europe Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
Table 56. China Ifosfamide (CAS 3778-73-2) Sales (Kg) by Company (2015-2020)
Table 57. China Ifosfamide (CAS 3778-73-2) Sales Market Share by Company (2015-2020)
Table 58. China Ifosfamide (CAS 3778-73-2) Sales (Kg) by Type (2015-2020)
Table 59. China Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
Table 60. China Ifosfamide (CAS 3778-73-2) Sales (Kg) by Application (2015-2020)
Table 61. China Ifosfamide (CAS 3778-73-2) Sales Market Share by Application (2015-2020)
Table 62. Japan Ifosfamide (CAS 3778-73-2) Sales (Kg) by Company (2015-2020)
Table 63. Japan Ifosfamide (CAS 3778-73-2) Sales Market Share by Company (2015-2020)
Table 64. Japan Ifosfamide (CAS 3778-73-2) Sales (Kg) by Type (2015-2020)
Table 65. Japan Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
Table 66. Japan Ifosfamide (CAS 3778-73-2) Sales (Kg) by Application (2015-2020)
Table 67. Japan Ifosfamide (CAS 3778-73-2) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Ifosfamide (CAS 3778-73-2) Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Ifosfamide (CAS 3778-73-2) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Ifosfamide (CAS 3778-73-2) Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Ifosfamide (CAS 3778-73-2) Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Ifosfamide (CAS 3778-73-2) Sales Market Share by Application (2015-2020)
Table 74. India Ifosfamide (CAS 3778-73-2) Sales (Kg) by Company (2015-2020)
Table 75. India Ifosfamide (CAS 3778-73-2) Sales Market Share by Company (2015-2020)
Table 76. India Ifosfamide (CAS 3778-73-2) Sales (Kg) by Type (2015-2020)
Table 77. India Ifosfamide (CAS 3778-73-2) Sales Market Share by Type (2015-2020)
Table 78. India Ifosfamide (CAS 3778-73-2) Sales (Kg) by Application (2015-2020)
Table 79. India Ifosfamide (CAS 3778-73-2) Sales Market Share by Application (2015-2020)
Table 80. Lingnan Pharma Corporation Information
Table 81. Lingnan Pharma Description and Business Overview
Table 82. Lingnan Pharma Ifosfamide (CAS 3778-73-2) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Lingnan Pharma Ifosfamide (CAS 3778-73-2) Product
Table 84. Lingnan Pharma Recent Development
Table 85. Qilu Pharma Corporation Information
Table 86. Qilu Pharma Description and Business Overview
Table 87. Qilu Pharma Ifosfamide (CAS 3778-73-2) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Qilu Pharma Ifosfamide (CAS 3778-73-2) Product
Table 89. Qilu Pharma Recent Development
Table 90. Ruiying Pharma Corporation Information
Table 91. Ruiying Pharma Description and Business Overview
Table 92. Ruiying Pharma Ifosfamide (CAS 3778-73-2) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Ruiying Pharma Ifosfamide (CAS 3778-73-2) Product
Table 94. Ruiying Pharma Recent Development
Table 95. Quanxing Pharma Corporation Information
Table 96. Quanxing Pharma Description and Business Overview
Table 97. Quanxing Pharma Ifosfamide (CAS 3778-73-2) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Quanxing Pharma Ifosfamide (CAS 3778-73-2) Product
Table 99. Quanxing Pharma Recent Development
Table 100. Baxter Corporation Information
Table 101. Baxter Description and Business Overview
Table 102. Baxter Ifosfamide (CAS 3778-73-2) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Baxter Ifosfamide (CAS 3778-73-2) Product
Table 104. Baxter Recent Development
Table 105. Hengrui Medicine Corporation Information
Table 106. Hengrui Medicine Description and Business Overview
Table 107. Hengrui Medicine Ifosfamide (CAS 3778-73-2) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Hengrui Medicine Ifosfamide (CAS 3778-73-2) Product
Table 109. Hengrui Medicine Recent Development
Table 110. Jinrui Pharma Corporation Information
Table 111. Jinrui Pharma Description and Business Overview
Table 112. Jinrui Pharma Ifosfamide (CAS 3778-73-2) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Jinrui Pharma Ifosfamide (CAS 3778-73-2) Product
Table 114. Jinrui Pharma Recent Development
Table 115. Taisheng Zhiyao Corporation Information
Table 116. Taisheng Zhiyao Ifosfamide (CAS 3778-73-2) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Taisheng Zhiyao Description and Business Overview
Table 118. Taisheng Zhiyao Ifosfamide (CAS 3778-73-2) Product
Table 119. Taisheng Zhiyao Recent Development
Table 120. TEVA Corporation Information
Table 121. TEVA Ifosfamide (CAS 3778-73-2) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. TEVA Description and Business Overview
Table 123. TEVA Ifosfamide (CAS 3778-73-2) Product
Table 124. TEVA Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Ifosfamide (CAS 3778-73-2) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Mylan Ifosfamide (CAS 3778-73-2) Product
Table 129. Mylan Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Ifosfamide (CAS 3778-73-2) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Pfizer Ifosfamide (CAS 3778-73-2) Product
Table 134. Pfizer Recent Development
Table . GLS Pharma Corporation Information
Table . GLS Pharma Description and Business Overview
Table . GLS Pharma Ifosfamide (CAS 3778-73-2) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . GLS Pharma Ifosfamide (CAS 3778-73-2) Product
Table . GLS Pharma Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Ifosfamide (CAS 3778-73-2) Distributors List
Table 143. Ifosfamide (CAS 3778-73-2) Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Ifosfamide (CAS 3778-73-2) Product Picture
Figure 2. Global Ifosfamide (CAS 3778-73-2) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Ifosfamide (CAS 3778-73-2) Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Ifosfamide (CAS 3778-73-2) Sales (Kg) Growth Rate (2015-2026)
Figure 10. Global Ifosfamide (CAS 3778-73-2) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Ifosfamide (CAS 3778-73-2) Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Ifosfamide (CAS 3778-73-2) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Ifosfamide (CAS 3778-73-2) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Ifosfamide (CAS 3778-73-2) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Ifosfamide (CAS 3778-73-2) Sales (Kg) Growth Rate (2015-2026)
Figure 16. Europe Ifosfamide (CAS 3778-73-2) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Ifosfamide (CAS 3778-73-2) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Ifosfamide (CAS 3778-73-2) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Ifosfamide (CAS 3778-73-2) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Ifosfamide (CAS 3778-73-2) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Ifosfamide (CAS 3778-73-2) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Ifosfamide (CAS 3778-73-2) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Ifosfamide (CAS 3778-73-2) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Ifosfamide (CAS 3778-73-2) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Ifosfamide (CAS 3778-73-2) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Ifosfamide (CAS 3778-73-2) Players Market Share by Revenue in Ifosfamide (CAS 3778-73-2) 2015 & 2019
Figure 27. Ifosfamide (CAS 3778-73-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Ifosfamide (CAS 3778-73-2) Revenue Share by Type (2015-2020)
Figure 29. Global Ifosfamide (CAS 3778-73-2) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Ifosfamide (CAS 3778-73-2) Revenue Share by Application (2015-2020)
Figure 31. Global Ifosfamide (CAS 3778-73-2) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Ifosfamide (CAS 3778-73-2) Sales Market Share by Type in 2019
Figure 33. United States Ifosfamide (CAS 3778-73-2) Sales Market Share by Type in 2019
Figure 34. Europe Ifosfamide (CAS 3778-73-2) Sales Market Share by Company in 2019
Figure 35. Europe Ifosfamide (CAS 3778-73-2) Sales Market Share by Type in 2019
Figure 36. Europe Ifosfamide (CAS 3778-73-2) Sales Market Share by Application in 2019
Figure 37. China Ifosfamide (CAS 3778-73-2) Sales Market Share by Company in 2019
Figure 38. China Ifosfamide (CAS 3778-73-2) Sales Market Share by Type in 2019
Figure 39. China Ifosfamide (CAS 3778-73-2) Sales Market Share by Application in 2019
Figure 40. Japan Ifosfamide (CAS 3778-73-2) Sales Market Share by Company in 2019
Figure 41. Japan Ifosfamide (CAS 3778-73-2) Sales Market Share by Type in 2019
Figure 42. Japan Ifosfamide (CAS 3778-73-2) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Ifosfamide (CAS 3778-73-2) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Ifosfamide (CAS 3778-73-2) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Ifosfamide (CAS 3778-73-2) Sales Market Share by Application in 2019
Figure 46. India Ifosfamide (CAS 3778-73-2) Sales Market Share by Company in 2019
Figure 47. India Ifosfamide (CAS 3778-73-2) Sales Market Share by Type in 2019
Figure 48. India Ifosfamide (CAS 3778-73-2) Sales Market Share by Application in 2019
Figure 49. Lingnan Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Qilu Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Ruiying Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Quanxing Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Jinrui Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Taisheng Zhiyao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. TEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. GLS Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Ifosfamide (CAS 3778-73-2)
Figure 63. Manufacturing Process Analysis of Ifosfamide (CAS 3778-73-2)
Figure 64. Ifosfamide (CAS 3778-73-2) Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
バイアルボックスの世界市場レポート2020 A recently published report by QY Research titled Global Vial Box Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a…- 極低温バイアルラックの世界市場レポート2020 A recently published report by QY Research titled Global Cryogenic Vial Rack Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurat…
- 特殊バイアルの世界市場レポート2020 A recently published report by QY Research titled Global Speciality Vial Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…
- バイアル充填およびキャッピングマシンの世界市場レポート2020 A recently published report by QY Research titled Global Vial Filling and Capping Machine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically pro…
- 管状バイアルの世界市場レポート2020 A tubular vial (tubular glass vial) is made of long glass tubes with a rigid wall thickness; the tubing is then sliced to proper lengths to make the vial. The preferred standpoint to tubing vials is that the divider is uniform in thickness and the base of the vial is level (versus arched in a formed…